IP Library Granted Patent US 7,943,733
Granted Patent B2
US 7,943,733 · App. 12/340,391 · Granted May 17, 2011

Spacers to increase the expression of recombinant fusion proteins

Assignee: University of Southern California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,943,733
App. No.
12/340,391
Granted
May 17, 2011
Kind
B2
Abstract

The present invention relates to fusion proteins. The invention specifically relates to compositions and methods of Tf-based fusion proteins that demonstrate a high-level expression of transferrin (Tf)-based fusion proteins by inserting a helical linker between two protein domains.

Claims (10)

1. A two-domain fusion protein construct for improving expression of a fusion protein having a first protein domain and a second protein domain, said construct comprising:

an alpha-helical peptide linker inserted between said first and second domains of the fusion protein,

wherein inclusion of said alpha-helical peptide linker in said fusion protein increases the expression level of said fusion protein as compared to fusion proteins comprising said two domains without said linker.

2. The fusion protein construct according to claim 1 , wherein said alph-helical peptide linker comprises more than one helical motif between said first and second domains.

3. The fusion protein construct according to claim 1 , wherein said alpha-helical peptide linker comprises LEA(EAAAK) 4 ALE (SEQ ID NO: 1).

4. The fusion protein construct according to claim 1 , wherein:

said first protein domain comprises a carrier protein selected from the group consisting of a transferrin, a serum albumin, an antibody and sFv; and

said second protein domain comprises a therapeutic protein selected from the group consisting of a colony stimulating factor (CSF), an interferon, a cytokine, a hormone, a lymphokine, an interleukin, a hematopoietic growth factor, and a toxin.

5. The fusion protein construct according to claim 4 , wherein said second protein domain comprises a granulocyte colony stimulating factor (G-CSF) or a human growth hormone (hGH).

6. The fusion protein construct according to claim 1 , wherein said first protein domain is a transferrin (Tf)-based protein domain.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 9, 2010
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024810/0951 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2009
From: SHEN, WEI-CHIANG; AMET, NURMAMET; CHEN, XIAOYING; LEE, HSIN-FANG
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 022310/0745 →
CONFIRMATORY LICENSE Recorded Jan 29, 2009
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022171/0642 →
Continuity (2)
Provisional Application 61015580 · Dec 20, 2007
Related Publication 20090170163A1 · Jul 2, 2009